DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Quinagolide

Quinagolide

  • Hyperprolactinaemia: a Monster Between the Woman and Her Conception *Seriki A

    Hyperprolactinaemia: a Monster Between the Woman and Her Conception *Seriki A

  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

    Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

  • Stereotactic Radiosurgery for Pituitary Tumors

    Stereotactic Radiosurgery for Pituitary Tumors

  • Guidance on the Treatment of Antipsychotic Induced Hyperprolactinaemia in Adults

    Guidance on the Treatment of Antipsychotic Induced Hyperprolactinaemia in Adults

  • POISONS LIST APPENDIX Amoebicides: Carbarsone

    POISONS LIST APPENDIX Amoebicides: Carbarsone

  • Summary of Product Characteristics

    Summary of Product Characteristics

  • Pharmacotherapy for Stimulant Use Disorders: a Systematic Review

    Pharmacotherapy for Stimulant Use Disorders: a Systematic Review

  • Pharmacological Aspects and Potential New Clinical Applications of Taurine and Bromocriptine

    Pharmacological Aspects and Potential New Clinical Applications of Taurine and Bromocriptine

  • Centre for Reviews and Dissemination

    Centre for Reviews and Dissemination

  • ( 12 ) United States Patent

    ( 12 ) United States Patent

  • New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A

    New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A

  • Benign Intracranial Hypertension Associated with the Withdrawal of a Non-Ergot Dopamine Agonist

    Benign Intracranial Hypertension Associated with the Withdrawal of a Non-Ergot Dopamine Agonist

  • Cabergoline and the Risk of Valvular Lesions in Endocrine Disease

    Cabergoline and the Risk of Valvular Lesions in Endocrine Disease

  • Medical Treatment of Prolactinomas Annamaria Colao and Silvia Savastano

    Medical Treatment of Prolactinomas Annamaria Colao and Silvia Savastano

  • Marleen BW.Indd

    Marleen BW.Indd

  • Hyperprolactinemia

    Hyperprolactinemia

  • Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists

    Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists

  • Poisons Standard February 2020

    Poisons Standard February 2020

Top View
  • Preclinical and Clinical Experiences with the Role of Dopamine Receptors in the Treatment of Pituitary Adenomas
  • Product Information
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • View the PDF Document
  • Dopamine Dopamine Serotonin Lisuride
  • QUINAGOLIDE SUMMARY SHEET TRADE NAME: Norprolac Licensed
  • Psychological Effects of Dopamine Agonist Treatment in Patients With
  • Chapter 1: Hyperprolactinemia and Woman's Health
  • Comparative Analyses of Semen and Endocrine Characteristics of Free-Living Versus Captive Jaguars (Panthera Onca)
  • Prolactin Secretion in Women: Narrative Review
  • Draft Package Insert
  • ESE Clinical Practice Guideline on Functioning and Nonfunctioning Pituitary Adenomas in Pregnancy
  • Solutions Your Api Intermediates
  • An Inventory of Medicinal Products Causing Skin Rash: Clinical and Regulatory Lessons
  • Withdrawal of Medical Therapy in Prolactinomas
  • Adverse Drug Reactions to Dopamine Agonists: a Comparative Study in the French Pharmacovigilance Database
  • Contemporary Management of Prolactinomas
  • Cabergoline Or Quinagolide Versus Bromocriptine for Hyperprolactinemia with Or Without Prolactinoma: Clinical Effectiveness, Cost- Effectiveness, and Guidelines


© 2024 Docslib.org    Feedback